The anti-malarial drug hydroxychloroquine, which the U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk of death in hospitalized COVID-19 patients, a large study published on Friday showed. In the study that looked at more than 96,000 people hospitalized with COVID-19, the respiratory disease caused by the novel Coronavirus, those treated with hydroxychloroquine or the related chloroquine had higher risk of death and heart rhythm problems than patients who were not given the medicines. The study, published in the Lancet medical journal, showed no benefit for Coronavirus patients taking the drugs. Demand for the decades-old hydroxychloroquine has surged as Trump repeatedly promoted its use against the Coronavirus, urging people to try it. “What have you got to lose?” he asked.
Zambia Reports Unconventional fresh perspectives outside the mainstream voices in public, featuring original submissions from reporters and bloggers within Zambia and among the diaspora.